- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: Apatinib SHR-1210(Camrelizumab)
I alt 299 resultater
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.UkendtMetastatisk tyktarmskræftKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRekrutteringKemoterapi effekt | BCLC Stadium C Hepatocellulært karcinomKina
-
West China HospitalRekruttering
-
Zhongshan Hospital Xiamen UniversityUkendtKolorektal cancer tilbagevendendeKina
-
Tianjin Medical University Cancer Institute and...Ukendt
-
Quan WangAfsluttetNeoplasmer i mavenKina
-
Sun Yat-sen UniversityAfsluttetMavekræft Stadium IV | EBVKina
-
Huiqiang HuangRekrutteringDiffust storcellet B-celle lymfom | Højgradigt B-celle lymfom | Transformeret lymfom | EBV-positiv DLBCL, nr | ALK-positivt anaplastisk storcellet lymfom | Follikulært lymfom grad IIIbKina
-
Wan-Guang ZhangRekrutteringMakrotrabekulært massivt hepatocellulært karcinomKina
-
Jiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterende
-
GlaxoSmithKlineAfsluttetNeoplasmer, brystForenede Stater, Korea, Republikken
-
Shanghai Zhongshan HospitalRekrutteringHepatocellulært karcinom | Immunterapi | Molekylær målrettet terapiKina
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.RekrutteringC-stadium hepatocellulært karcinom i BCLC-klassificeringKina
-
SYZ Cell Therapy Co..Peking University Cancer Hospital & InstituteUkendtAvanceret mavekræftKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuStadie IV Esophagus planocellulært karcinomKina
-
GlaxoSmithKlineAfsluttetStreptococcus Pneumoniae-vaccinerSverige
-
Beijing Friendship HospitalUkendt
-
Zhongda HospitalAktiv, ikke rekrutterendeTACE kombineret med Camrelizumab og Apatinib ved mellemliggende og avanceret hepatocelluært karcinomHepatocellulært karcinomKina
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; Guangdong...Aktiv, ikke rekrutterendeKolorektal cancer | Mikrosatellit-ustabilitet højKina
-
Guangdong Association of Clinical TrialsIkke rekrutterer endnu
-
Henan Cancer HospitalFirst Affiliated Hospital Xi'an Jiaotong UniversityRekrutteringEsophageal carcinom | Lungekræft, ikke-småcelletKina
-
Nanfang Hospital of Southern Medical UniversityRekruttering
-
Shanghai Pulmonary Hospital, Shanghai, ChinaAktiv, ikke rekrutterendeIkke småcellet lungekræftKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAktiv, ikke rekrutterende
-
Peking Union Medical College HospitalAfsluttetGestationel trofoblastisk sygdomKina
-
Sun Yat-sen UniversityRekrutteringHepatocellulært karcinomKina
-
Chinese PLA General HospitalRekruttering
-
Cancer Institute and Hospital, Chinese Academy...UkendtEsophageal pladecellekarcinomKina
-
Shanghai Chest HospitalIkke rekrutterer endnuEsophageal pladecellekarcinomKina
-
Shanghai Jiao Tong University School of MedicineRekrutteringOralt planocellulært karcinom | Anti-PD-1 | Neoadjvant terapi | Anti-VEGFRKina
-
Chinese PLA General HospitalUkendtAvanceret mavekræftKina
-
Cancer Hospital of Guangxi Medical UniversityUkendtHepatocellulært karcinomKina
-
Shanghai Zhongshan HospitalJiangsu HengRui Medicine Co., Ltd.Ukendt
-
Zhou ChengzhiJiangsu Hengrui Pharmaceutical Co., Ltd.RekrutteringSmåcellet lungekræft i omfattende stadieKina
-
Peking University Cancer Hospital & InstituteRekrutteringIkke-operabelt hepatocellulært karcinomKina
-
R-PharmGlaxoSmithKlineAfsluttetLokalt avanceret eller metastatisk brystkræftForenede Stater, Italien, Australien
-
Henan Cancer HospitalRekrutteringKlassisk Hodgkin lymfomKina
-
Henan Cancer HospitalUkendt
-
Peking Union Medical College HospitalUkendtTilbagevendende platin-resistent ovariekræftKina
-
The First Affiliated Hospital of Xiamen UniversityIkke rekrutterer endnu
-
Sun Yat-sen UniversityUkendtIkke småcellet lungekræftKina
-
Fuzhou General HospitalUkendtSmåcellet lungekræft | Lunge-neoplasma | PD-1 hæmmereKina
-
Manjunath Prakash PaiPfizerAfsluttet
-
Zhongshan Hospital Xiamen UniversityUkendtLevermetastase af kolorektal cancerKina
-
China Medical University, ChinaRekruttering
-
Fujian Medical UniversityIkke rekrutterer endnu
-
Peking University People's HospitalChinese Sarcoma Study GroupRekrutteringOsteosarkom | Kemoterapi effekt | Overlevelse | Toksicitet, lægemiddelKina
-
Shandong Cancer Hospital and InstituteJiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterende
-
Jiangsu HengRui Medicine Co., Ltd.AfsluttetTredobbelt negativ brystkræftKina
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Temozolomid | Apatinib | Camrelizumab | Akralt melanom | Neoadjuvans | Patologisk responsKina